KRAS mutation confers resistance to antibody-dependent cellular cytotoxicity of cetuximab against human colorectal cancer cells.

KRAS mutation confers resistance to antibody-dependent cellular cytotoxicity of cetuximab against human colorectal cancer cells.

Item
http://www.wikidata.org/entity/Q39077167
Combination of a Selective HSP90α/β Inhibitor and a RAS-RAF-MEK-ERK Signaling Pathway Inhibitor Triggers Synergistic Cytotoxicity in Multiple Myeloma Cells.Evaluation of antibody-dependent cell-mediated cytotoxicity activity and cetuximab response in KRAS wild-type metastatic colorectal cancer patients.A novel method for evaluating antibody-dependent cell-mediated cytotoxicity by flowcytometry using cryopreserved human peripheral blood mononuclear cells.miR-143 or miR-145 overexpression increases cetuximab-mediated antibody-dependent cellular cytotoxicity in human colon cancer cells.TIMP-1 is under regulation of the EGF signaling axis and promotes an aggressive phenotype in KRAS-mutated colorectal cancer cells: a potential novel approach to the treatment of metastatic colorectal cancer.Beyond KRAS status and response to anti-EGFR therapy in metastatic colorectal cancer.A Phase II Efficacy and Safety, Open-Label, Multicenter Study of Imprime PGG Injection in Combination With Cetuximab in Patients With Stage IV KRAS-Mutant Colorectal Cancer.Development of a bispecific antibody tetramerized through hetero-associating peptides.Targeting the Epidermal Growth Factor Receptor Can Counteract the Inhibition of Natural Killer Cell Function Exerted by Colorectal Tumor-Associated Fibroblasts.KRAS RENAISSANCE(S) in Tumor Infiltrating B Cells in Pancreatic Cancer
P2860

KRAS mutation confers resistance to antibody-dependent cellular cytotoxicity of cetuximab against human colorectal cancer cells.

Item
http://www.wikidata.org/entity/Q39077167
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
KRAS mutation confers resistan ...... human colorectal cancer cells.
@en
KRAS mutation confers resistan ...... human colorectal cancer cells.
@nl
type
label
KRAS mutation confers resistan ...... human colorectal cancer cells.
@en
KRAS mutation confers resistan ...... human colorectal cancer cells.
@nl
prefLabel
KRAS mutation confers resistan ...... human colorectal cancer cells.
@en
KRAS mutation confers resistan ...... human colorectal cancer cells.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
KRAS mutation confers resistan ...... human colorectal cancer cells.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921